- Home
- PULM vs OXBR Comparison
PULM vs OXBR Comparison
Compare PULM & OXBR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | PULM | OXBR |
|---|---|---|
| Founded | 2003 | 2013 |
| Country | United States | Cayman Islands |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Property-Casualty Insurers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 13.6M | 11.0M |
| IPO Year | N/A | 2014 |
Fundamental Metrics
Financial Performance| Metric | PULM | OXBR |
|---|---|---|
| Price | $2.60 | $1.20 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $5.00 |
| AVG Volume (30 Days) | ★ 36.6K | 9.4K |
| Earning Date | 10-16-2025 | 11-06-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $3,000.00 | ★ $2,423,000.00 |
| Revenue This Year | N/A | $497.99 |
| Revenue Next Year | $134.88 | $42.14 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $2.15 | $1.12 |
| 52 Week High | $10.40 | $5.81 |
Technical Indicators
Market Signals| Indicator | PULM | OXBR |
|---|---|---|
| Relative Strength Index (RSI) | 45.14 | 38.68 |
| Support Level | $2.23 | $1.22 |
| Resistance Level | $2.70 | $1.34 |
| Average True Range (ATR) | 0.16 | 0.06 |
| MACD | 0.12 | -0.01 |
| Stochastic Oscillator | 88.78 | 0.00 |
Price Performance
Historical ComparisonAbout PULM Pulmatrix Inc.
Pulmatrix Inc is a biopharmaceutical company that has focused on the development of novel inhaled therapeutic products intended to prevent and treat migraine and respiratory diseases with important unmet medical needs using its patented dry powder delivery technology, iSPERSE. Its pipeline of clinical assets includes PUR3100 for the treatment of acute migraine, PUR1800 for the treatment of acute exacerbations of chronic obstructive pulmonary disease (AECOPD), and PUR1900 for the treatment of ABPA in patients with asthma and in patients with cystic fibrosis (CF).
About OXBR Oxbridge Re Holdings Limited
Oxbridge Re Holdings Ltd is a specialty property and casualty reinsurer. It provides reinsurance solutions through its subsidiary. It focuses on underwriting fully collateralized reinsurance contracts for property and casualty insurance companies in the Gulf Coast region of the United States, with an emphasis on Florida. Oxbridge specializes in underwriting medium frequency, high severity risks, where insufficient data exists to analyze effectively the risk/return profile of reinsurance contracts. The company manages its business on the basis of one operating segment, Property and Casualty Reinsurance.